Ethics approval
The trial was approved by the National Healthcare Group Domain Specific Review Board (2012/01035) and Centralised Institutional Review Board (2013/747/F). Written informed consent was obtained from all subjects and/or their legal guardian(s). The study was conducted in accordance with the Declaration of Helsinki.